Centinel Spine announced the 100th completed procedure in the U.S. with its prodisc® C Vivo Cervical Total Disc Replacement (TDR). This milestone was achieved after the company announced the first U.S. implantation of the prodisc C Vivo in September 2022.
The prodisc C Vivo system has been in clinical use internationally since 2009, and is reportedly one of the most frequently implanted TDR devices in the world. The device features keel-less fixation and combines an anatomically-designed superior endplate with lateral spikes to optimize fit and provide immediate fixation.
Centinel Spine’s cervical TDR portfolio includes four devices approved by FDA for 1-level indications, offering a broad spectrum of solutions to address surgeon preference and individual patient anatomy.
Centinel Spine announced the 100th completed procedure in the U.S. with its prodisc® C Vivo Cervical Total Disc Replacement (TDR). This milestone was achieved after the company announced the first U.S. implantation of the prodisc C Vivo in September 2022.
The prodisc C Vivo system has been in clinical use internationally since 2009, and is...
Centinel Spine announced the 100th completed procedure in the U.S. with its prodisc® C Vivo Cervical Total Disc Replacement (TDR). This milestone was achieved after the company announced the first U.S. implantation of the prodisc C Vivo in September 2022.
The prodisc C Vivo system has been in clinical use internationally since 2009, and is reportedly one of the most frequently implanted TDR devices in the world. The device features keel-less fixation and combines an anatomically-designed superior endplate with lateral spikes to optimize fit and provide immediate fixation.
Centinel Spine’s cervical TDR portfolio includes four devices approved by FDA for 1-level indications, offering a broad spectrum of solutions to address surgeon preference and individual patient anatomy.
Copy to clipboard 
